4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-013110
Options or other derivatives
- Chief Scientific Officer acquired 16,288 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Locke Kenneth W Chief Scientific Officer | 2015-02-10 | Grant or award · Stock Option (Right to Buy) | +16,288 | 16,288 | D | ||
Loading xslF345X03/doc4.xml…